SEC Form 4 · accession 0001209191-15-047902
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg Beloff
Officer — Interim CFO
Period of report
May 27, 2015
Accepted (ET)
May 29, 2015 · 3:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.89 | May 27, 2015 | A | 90,000 | A | — | May 26, 2025 | Common Stock | 90,000 | 90,000 | D |
Explanation of responses
- F1This option was granted on May 27, 2015. The option vests in twelve equal monthly installments over the one year period following the date of grant.